Affordable Access

deepdyve-link
Publisher Website

FOXO1 differentially regulates both normal and diabetic wound healing.

Authors
  • Zhang, Chenying
  • Ponugoti, Bhaskar
  • Tian, Chen
  • Xu, Fanxing
  • Tarapore, Rohinton
  • Batres, Angelika
  • Alsadun, Sarah
  • Lim, Jason
  • Dong, Guangyu
  • Graves, Dana T
Type
Published Article
Journal
Journal of Cell Biology
Publisher
Rockefeller University Press
Publication Date
Apr 27, 2015
Volume
209
Issue
2
Pages
289–303
Identifiers
DOI: 10.1083/jcb.201409032
PMID: 25918228
Source
Medline
License
Unknown

Abstract

Healing is delayed in diabetic wounds. We previously demonstrated that lineage-specific Foxo1 deletion in keratinocytes interfered with normal wound healing and keratinocyte migration. Surprisingly, the same deletion of Foxo1 in diabetic wounds had the opposite effect, significantly improving the healing response. In normal glucose media, forkhead box O1 (FOXO1) enhanced keratinocyte migration through up-regulating TGFβ1. In high glucose, FOXO1 nuclear localization was induced but FOXO1 did not bind to the TGFβ1 promoter or stimulate TGFβ1 transcription. Instead, in high glucose, FOXO1 enhanced expression of serpin peptidase inhibitor, clade B (ovalbumin), member 2 (SERPINB2), and chemokine (C-C motif) ligand 20 (CCL20). The impact of high glucose on keratinocyte migration was rescued by silencing FOXO1, by reducing SERPINB2 or CCL20, or by insulin treatment. In addition, an advanced glycation end product and tumor necrosis factor had a similar regulatory effect on FOXO1 and its downstream targets and inhibited keratinocyte migration in a FOXO1-dependent manner. Thus, FOXO1 expression can positively or negatively modulate keratinocyte migration and wound healing by its differential effect on downstream targets modulated by factors present in diabetic healing.

Report this publication

Statistics

Seen <100 times